The 1.7mg dose was not part of the original STEP trial protocol for semaglutide 2.4mg (which used 0.25, 0.5, 1.0, 1.7, then 2.4), but it serves as a crucial intermediate step that reduces the jump between 1.0mg and 2.4mg
Also available is Foundayo (orforglipron), a more recent oral GLP-1 option that offers patients flexibility by allowing consumption anytime, independent of food or water
Peptide therapy may not be recommended if you are pregnant, breastfeeding, actively fighting cancer, or have certain metabolic or autoimmune conditions
Knowing what supplements to take and even being disciplined to take them is important
The Vitalogy Weight Loss Membership Program Vitalogy Wellness and Med Spa now offers a dedicated weight loss membership program
Choosing the right treatment can be a game-changer when it comes to achieving significant weight loss